A Practical Guide to the Diagnosis, Management, and Treatment of Testosterone Deficiency for Canadian Physicians

Dr Alvaro Morales, MD, CM, FRCSC, FACS, DABU Program Chair Emeritus Professor of Urology Director, Centre for Applied Urological Research Queen’s University Kingston, Ontario

A Message from the Chair

Welcome to the Web site ManagingTD.ca - "A Practical Guide to the Diagnosis, Management and Treatment of Testosterone Deficiency for Canadian Physicians".

A significant number of physicians in Canada are uncertain of their clinical skills regarding the diagnosis and management of testosterone deficiency (TD). Participating in this program will help to make a profound difference to the perceived underdiagnosis and inadequate management of TD in Canada.

The content of this Web site has been peer-reviewed by family physicians, endocrinologists and urologists. Family physicians registering on the site may complete continuing education learning activities which qualify for The College of Family Physicians of Canada’s Mainpro-M1 credits. Specialists may also qualify for Royal College of Physicians and Surgeons’ Section 1 credits by participating in live events.

I hope you will greatly benefit from the educational content of this Web site resource.

Scientific Advisory Panel Members

Name, Titles & Affiliations:	Conflict of Interest Disclosures:
Program Chair:
Alvaro Morales, MD, CM, FRCSC, FACS, DABU Emeritus Professor of Urology Director, Centre for Applied Urological Research Queen’s University Kingston, Ontario	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited Consulting Fees: Other:
Urologists:
Anthony J. Bella, MD, FRCSC Assistant Professor of Urology, University of Ottawa Associate Scientist in Neuroscience Director of Urologic Basic Science Research Ottawa Health Research Institute Ottawa, Ontario	Relationships with commercial interests: Grants/Research Support: Canadian Foundation for Innovation, Canadian Male Sexual Health Council, Northeastern Section of the American Urological Association, ACORDA Therapeutics Speakers Bureau/Honoraria: Abbott Laboratories, Limited, American Medical Systems, Eli Lilly Canada Inc., and Pfizer Canada Inc. Consulting Fees: American Medical Systems, Eli Lilly Canada Inc., and Pfizer Canada Inc. Other:
Samuel Chun, MD, FRCSC Lecturer, Department of Urology Faculty of Medicine, Dalhousie University Halifax, Nova Scotia	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited, Bayer Inc., Eli Lilly Canada Inc., Johnson & Johnson Inc., Paladin Labs Inc. and Pfizer Canada Inc. Consulting Fees: Abbott Laboratories, Limited, and GlaxoSmithKline Inc Other:
Jay Lee, MD, FRCSC Clinical Lecturer, Department of Surgery Division of Urology, University of Calgary Rockyview General Hospital Calgary, Alberta	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited, Astellas, and Eli Lilly Canada Inc. Consulting Fees: Abbott Laboratories, Limited, Astellas, and Eli Lilly Canada Inc. Other:
Endocrinologists:
Peter Assimakopoulos, MD, FRCPC Assistant Professor, Department of Medicine McGill University Division of Endocrinology, Jewish General Hospital Montréal, Québec	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Amgen Canada, AstraZeneca Canada Inc., Boehringer Ingelheim Canada Ltd., Bristol-Myers Squibb Canada, Eli Lilly Canada Inc., Merck Canada Ltd., Novartis Canada and Sanofi Canada. Consulting Fees: Auxilium Pharmaceuticals Inc. Other:
Richard Bebb, MD, ABIM (IM/ENDO), FRCPC (IM/ENDO) Clinical Assistant Professor University of British Columbia Endocrinologist, St. Paul’s Hospital Vancouver, British Columbia	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited, AstraZeneca Canada Inc., Aventis, Bayer Inc., Eli Lilly Canada Inc. and Novo Nordisk Canada Inc. Consulting Fees: Abbott Laboratories, Limited, AstraZeneca Canada Inc., Aventis, Bayer Inc., Eli Lilly Canada Inc. and Novo Nordisk Canada Inc. Other: Ownership of stock or stock options: Vertex Pharma
Irv Gottesman, MD, FRCPC, FACP, FACE Assistant Professor, Faculty of Medicine, University of Toronto Director, Division of Endocrinology, Credit Valley Hospital Director, Bariatric & Metabolic Health Program Cleveland Clinic Canada (Toronto) Toronto, Ontario	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited, AstraZeneca Canada Inc., Boehringer Ingelheim Canada Ltd., Bristol-Myers Squibb Canada, Eli Lilly Canada Inc., Janssen-Ortho, Merck Frosst Canada Ltd., Novo Nordisk Canada Inc., Paladin Labs Inc., Valeant, Sanofi-Aventis. Consulting Fees: Other:
Family Physicians:
Pierre Alarie, MD Coordinator, Sexual Dysfunction Unit CHUM Hôpital St-Luc Montréal, Québec	Relationships with commercial interests: Grants/Research Support: Abbott Laboratories, Limited, Eli Lilly Canada Inc., Johnson & Johnson Inc., and Pfizer Canada Inc Speakers Bureau/Honoraria: Abbott Laboratories, Limited, Bayer Inc., Eli Lilly Canada Inc., Pfizer Canada Inc. and Schering-Plough Canada Inc. Consulting Fees: Abbott Laboratories, Limited and Eli Lilly Canada Inc. Other:
Hélène Dugré, MD Family Physician, Clinical Psychologist Unité des Dysfonctions Sexuelles Centre Hospitalier Université Montréal Hôpital St-Luc Montréal, Québec	Relationships with commercial interests: Grants/Research Support: Pfizer Canada Inc. Speakers Bureau/Honoraria: Abbott Laboratories, Limited, Eli Lilly Canada Inc., Pfizer Canada Inc., and Schering-Plough Canada. Consulting Fees: Eli Lilly Canada Inc Other:
Stacy Elliott, MD Clinical Professor, Dept. of Psychiatry & Urological Sciences Faculty & Principle Investigator, International Collaboration on Repair Discoveries (ICORD) University of British Columbia Medical Director, BC Centre for Sexual Medicine Vancouver Hospital Medical Director, Sexual Assessment and Rehabilitation Clinic Men’s Health Initiative Vancouver, British Columbia	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited and Eli Lilly Canada Inc. Consulting Fees: Other:
Family Physician Planning Committee:
John T. Axler, MD, CCFP Assistant Professor, Dept. of Family and Community Medicine University of Toronto Active Staff, Toronto East General Hospital Toronto, Ontario	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited, Amgen Canada Inc., Boehringer Ingelheim Canada Ltd., GlaxoSmithKline Inc., Eli Lilly Canada Inc., Merck Canada Inc., Bristol-Myers Squibb Consulting Fees: Other:
Brian Craig, MD, MCFP Head, Department of Family Medicine Lecturer, Dalhousie University Atlantic Health Sciences Saint John, New Brunswick	Relationships with commercial interests: Grants/Research Support: Boehringer Ingelheim Canada Ltd., GlaxoSmithKline Inc., Pfizer Canada Inc., Servier Speakers Bureau/Honoraria: Abbott Laboratories, Limited Consulting Fees: Amgen Canada Inc., AstraZeneca Canada Inc. Other:
Jean Desaulniers, MD, CCFP, FCFM CME President, Association des Médecins Omnipraticiens de Mauricie (AMOM) CHSLD Le Trifluvien Trois-Rivières, Québec	Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Abbott Laboratories, Limited Consulting Fees: Other: